AUPH - Now's the Time to Buy These 3 Stocks
What investor doesn't want to own a solid company with exciting prospects for business growth in the near- and mid-term? Healthcare stocks often provide a safe haven during uncertain market conditions. Here we explore a few interesting opportunities ranging from a big pharma name to a pre-revenue biotech.
Image Source: Getty Images.
If you want a solid stock that allows you to sleep soundly at night, buy Merck (NYSE: MRK). Keytruda, the company's flagship cancer drug, generated sales in excess of $3 billion in each of the last three quarters. It single-handedly delivers more than 25% of Merck's total sales. The drug is well on its way to being one of the biggest selling drugs of all time.